Pulsatile Perfusion Therapy Phase II

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

December 17, 2021

Study Completion Date

December 17, 2021

Conditions
Hemorrhage
Interventions
OTHER

0 Hz Control

Lower body negative pressure (LBNP) applied to -60 mmHg for 10-min

OTHER

0.1 Hz PPT

Lower body negative pressure (LBNP) applied at a frequency of 0.1 Hz from -30 mmHg to -90 mmHg

OTHER

0.05 Hz PPT

Lower body negative pressure (LBNP) applied at a frequency of 0.05 Hz from -30 mmHg to -90 mmHg

Trial Locations (1)

76107

University of North Texas Health Science Center, Fort Worth

All Listed Sponsors
lead

Caroline Rickards

OTHER

NCT05983744 - Pulsatile Perfusion Therapy Phase II | Biotech Hunter | Biotech Hunter